FDA issued a draft guidance for industry that, when finalized, will provide sponsors with recommendations for conducting multiregional clinical trials in support of applications for drugs intended to treat cancer.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
